Caring for older adults with lung cancer is incredibly complex, but it doesn't have to be overwhelming. The SIOG 2025 Roundtable Discussion, titled "Perspectives on Complexities in Treatment Selection for Older Adults with Lung Cancer," brought together a diverse group of experts to tackle this very challenge. Chaired by Fabio Gomes from Manchester, the discussion offered a deep dive into the nuances of treating older patients, a critical area in oncology. But here's where it gets interesting...
The roundtable centered around a real-life clinical case of an elderly patient newly diagnosed with lung cancer. This case served as a springboard to explore the many factors that influence treatment decisions. These factors often go beyond standard guidelines. We're talking about diagnostic uncertainties, the patient's overall health, functional limitations, and competing priorities. The session began by presenting the patient's initial symptoms, diagnostic findings, and early treatment steps to set the stage for a rich discussion.
Why do specialists sometimes see the same patient so differently? Under the guidance of Prof. Lore Decoster, the panel explored the case from both pulmonology and geriatric oncology perspectives. The discussion highlighted how different specialists might approach imaging, biopsy decisions, and risk assessment based on their specific expertise. It also revealed how crucial details, like functional abilities and psychosocial factors, can sometimes be overlooked when geriatric expertise isn't included in the multidisciplinary tumor board meetings.
The patient's treatment journey then took a turn. Systemic therapy was initiated without a geriatric assessment, and the patient soon experienced significant toxicity, disrupting the treatment plan. This sparked a broader conversation about what could have been anticipated: frailty indicators, the impact of multiple medications, cognitive issues, or even a decline in physical function. These are all things that routine oncology check-ups often miss. Panelists noted that many of these complications are predictable and sometimes preventable when geriatric principles guide the decision-making process.
So, how can we improve this situation? Siri Rostoft from Oslo and Theodora Karnakis from São Paulo presented practical solutions. They explained how geriatric assessments can be integrated into lung cancer care. Even simple screening tools can identify vulnerabilities that influence treatment decisions, including medication dosages, the intensity of treatment, and the need for supportive care. They emphasized that geriatric assessment isn't just an extra step; it's a crucial safety measure that leads to more personalized and realistic treatment plans.
And this is the part most people miss... Audience members from various regions shared their experiences, describing cases where the absence of geriatric assessment led to overly aggressive treatments, avoidable toxicities, and missed opportunities for supportive care. The discussion highlighted the global challenge of treating older adults with lung cancer who often face a complex web of medical, functional, and social issues.
In his closing remarks, Fabio Gomes reiterated the key takeaway from the roundtable: improving outcomes for older adults with lung cancer requires a coordinated, multidisciplinary approach that is informed by geriatric principles. Diagnostics, treatment planning, and toxicity management must consider the whole patient, not just the tumor. Integrating geriatric assessments, establishing structured pathways, and recognizing when a more measured approach is safer are essential steps toward better care.
What do you think? Does this perspective change how you view lung cancer treatment for older adults? Do you agree that a multidisciplinary approach is essential? Share your thoughts in the comments below!
